New: NCI-funded clinical trial search
Mednet Logo
Events
American College of Rheumatology×Mednet

From plenary to practice.

Orlando, Florida

ACR has partnered with Mednet to turn select sessions into peer discussions. Create an account to get notified when they go live.

First discussion opens Sunday, November 8.

Sessions covered

  1. Cellular Immunotherapy: Are We on the Cusp of a Therapeutic Revolution in Rheumatology? Session 1

    1:00 – 2:15 pm ET

    Speakers

    • Georg Schett, MD · Uniklinikum Erlangen
    • Grant Hughes, MD · University of Washington
    • Anca Askanase, MD, MPH · Hospital for Special Surgery

  2. Diagnosis and Management of Sjögren’s Disease: Optimal Care in a New Era

    8:00 – 9:30 am ET

    Speakers

    • Ghaith Noaiseh, MD · University of Kansas Medical Center
    • Benjamin A. Fisher, MD, MBBS · University of Birmingham
    • Raphaèle Seror, MD, PhD · University Hospital Paris Saclay

  3. Modern Solutions to a Vintage Disease: Paradigm Shifts in the Management of Gout

    10:00 – 11:30 am ET

    Speakers

    • Hyon K. Choi, MD, MPH, DrPH · Massachusetts General Hospital
    • Naomi Schlesinger, MD · University of Utah
    • Michael Pillinger, MD · New York University Grossman School of Medicine

  4. Cellular Immunotherapy: Are We on the Cusp of a Therapeutic Revolution in Rheumatology? Session 2

    1:00 – 2:15 pm ET

    Speakers

    • Nirali Shah · National Institutes of Health
    • Anam Tariq, DO, MHS · FDA
    • Anca Askanase, MD, MPH · Hospital for Special Surgery

  5. Cellular Immunotherapy: Are We on the Cusp of a Therapeutic Revolution in Rheumatology? Session 3

    1:00 – 2:20 pm ET

    Speakers

    • Leila Khalili, MSN, FNP, APRN · Hospital for Special Surgery
    • Hermine Brunner, MD, MSc, MBA · Cincinnati Children’s Hospital Medical Center
    • Georg Schett, MD · Uniklinikum Erlangen
    • George Tsokos, MD, MACR · Beth Israel Deaconess Medical Center
Jonathan Samuels, MD

“It's great to read the varying perspectives from more than one colleague on the same topic and see where they diverge or converge in their opinions. Many of the topics are directly relevant to issues I face daily, so it has facilitated some quick literature review and helped me provide the best care possible for my patients.”

Jonathan Samuels, MD

Rheumatology

NYU Langone Health

WHAT IS MEDNET

Where physicians weigh in

Beyond the meeting, Mednet is where physicians compare how they actually practice. Every answer carries a name and a credential.

Mednet Community

Mednet Member

Rheumatology

How are you sequencing therapy in RA after a first TNF inhibitor fails?

13 replies9 agreedRheumatology
Invited Expert

Mednet Expert

Rheumatology • NYU Langone Health

If the failure looks like secondary loss of response I check drug levels and antibodies before switching class. For primary non-response I move out of the class early, usually to a JAK inhibitor or abatacept depending on comorbidity and CV risk...

1 in 3

That's how often physicians change their patient approach based on something they read on Mednet.